Pei Fei, Jiang Junjie, Bai Shuyun, Cao Henghua, Tian Luyang, Zhao Ya, Yang Chuanxiu, Dong Haiheng, Ma Yue
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China; Medical School of University of Chinese Academy of Sciences, Beijing 100101, China.
Biology Unit, Research Division, WuXi AppTec Co., Ltd., Shanghai 200131, China.
Stem Cell Res. 2017 Mar;19:94-103. doi: 10.1016/j.scr.2017.01.006. Epub 2017 Jan 12.
Most existing culture media for cardiac differentiation of human pluripotent stem cells (hPSCs) contain significant amounts of albumin. For clinical transplantation applications of hPSC-derived cardiomyocytes (hPSC-CMs), culturing cells in an albumin containing environment raises the concern of pathogen contamination and immunogenicity to the recipient patients. In addition, batch-to-batch variation of albumin may cause the inconsistent of hPSC cardiac differentiation. Here, we demonstrated that antioxidants l-ascorbic acid, trolox, N-acetyl-l-cysteine (NAC) and sodium pyruvate could functionally substitute albumin in the culture medium, and formulated an albumin-free, chemical-defined medium (S12 medium). We showed that S12 medium could support efficient hPSC cardiac differentiation with significantly improved reproducibility, and maintained long-term culture of hPSC-CMs. Furthermore, under chemical-defined and albumin-free conditions, human-induced pluripotent stem cells (hiPSCs) were established, and differentiated into highly homogenous atrial and ventricular myocytes in a scalable fashion with normal electrophysiological properties. Finally, we characterized the activity of three typical cardiac ion channels of those cells, and demonstrated that hPSC-derived ventricular cardiomyocytes (hPSC-vCMs) were suitable for drug cardiac safety evaluation. In summary, this simplified, chemical-defined and albumin-free culture medium supports efficient generation and maintaining of hPSC-CMs and facilitates both research and clinical applications of these cells.
大多数现有的用于人类多能干细胞(hPSC)心脏分化的培养基都含有大量白蛋白。对于hPSC来源的心肌细胞(hPSC-CM)的临床移植应用,在含有白蛋白的环境中培养细胞会引发对病原体污染和对受体患者免疫原性的担忧。此外,白蛋白的批次间差异可能导致hPSC心脏分化的不一致。在此,我们证明了抗氧化剂l-抗坏血酸、生育三烯酚、N-乙酰-l-半胱氨酸(NAC)和丙酮酸钠可以在功能上替代培养基中的白蛋白,并配制了一种无白蛋白、化学成分明确的培养基(S12培养基)。我们表明,S12培养基可以支持高效的hPSC心脏分化,具有显著提高的可重复性,并能维持hPSC-CM的长期培养。此外,在化学成分明确且无白蛋白的条件下,建立了人类诱导多能干细胞(hiPSC),并以可扩展的方式分化为具有正常电生理特性的高度同质的心房和心室肌细胞。最后,我们对这些细胞的三种典型心脏离子通道的活性进行了表征,并证明hPSC来源的心室心肌细胞(hPSC-vCM)适用于药物心脏安全性评估。总之,这种简化的、化学成分明确且无白蛋白的培养基支持高效生成和维持hPSC-CM,并促进这些细胞的研究和临床应用。